13F-HR filed by Defilade Capital Management, L.P.
Defilade Capital Management, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 20:30:58 UTC, with 30 holding rows worth $598,799,890.
- Accession
- 0002088557-26-000010
- Filer
- CIK 2088557
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 30 entries on the cover page, a total value of $598,799,890 stated on the cover page (in dollars after the unit check, H1), rows summing to $598,799,890 with VALUE read as dollars as filed, 13F file number 028-26338. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Pfizer Inc. | 717081103 | COM | 1,524,999 | $43,492,971 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 34,774 | $40,236,300 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 601,922 | $36,115,320 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 226,572 | $33,770,557 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 175,371 | $32,336,659 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 74,079 | $31,225,039 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 2,272,497 | $30,610,535 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 128,858 | $29,357,718 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 71,860 | $29,220,432 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 81,524 | $22,450,894 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 652,377 | $21,065,253 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 631,645 | $20,225,273 | dollars as filed | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 69,141 | $19,736,298 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 332,200 | $19,387,192 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 570,318 | $18,963,074 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 26,469 | $17,867,898 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,275,512 | $17,453,177 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 4,934,439 | $15,765,533 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 350,778 | $15,311,460 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 71,186 | $14,611,638 | dollars as filed | |
| SOLVENTUM CORP COM SHS | 83444M101 | Stock | 165,673 | $14,604,075 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 534,430 | $12,543,072 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,440,157 | $12,442,956 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 1,430,573 | $11,816,533 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 3,525,338 | $8,919,105 | dollars as filed | |
| ICU MED INC | 44930G107 | COM | 54,435 | $8,737,362 | dollars as filed | |
| ENOVIS CORPORATION | 194014502 | COM | 399,651 | $7,301,624 | dollars as filed | |
| PACS GROUP INC | 69380Q107 | COM SHS | 164,984 | $6,855,085 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 1,770,948 | $3,338,237 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 7,558,756 | $3,038,620 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002088557-26-000010 | this filing | 2026-11-16 |